Asunaprevir: Optimizing HCV NS3 Protease Inhibition in An...
2025-10-21
Asunaprevir (BMS-650032) stands out as a versatile HCV NS3 protease inhibitor, enabling precise, high-throughput hepatitis C research across diverse cell systems. This guide delivers actionable protocols, advanced troubleshooting, and comparative insights to maximize experimental success and drive innovation in antiviral development.